World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 May 2021
Main ID:  JPRN-UMIN000043344
Date of registration: 10/04/2021
Prospective Registration: No
Primary sponsor: faculty of medicine diponegoro university
Public title: Effect of channa striata on tuberculosis in children
Scientific title: The effect of channa striata on tuberculosis outcome in children - effect channa striata on body mass index, Leptin level, albumin level, TNF-s, IFN-gamma in tuberculosis children
Date of first enrolment: 2020/08/01
Target sample size: 70
Recruitment status: Recruiting
URL:  https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049490
Study type:  Interventional
Study design:  Parallel Randomized  
Phase:  Phase III
Countries of recruitment
Asia(except Japan)
Contacts
Name: MOH SYAROFIL   ANAM
Address:  Bagian/KSM Ilmu Kesehatan Anak FK Undip/RSUP dr. Kariadi Semarang. Jl. dr Sutomo No.16. Gedung C1L2 50244 Japan
Telephone: 0248414296
Email: msanam77@fk.undip.ac.id
Affiliation:  lecturer at diponegoro university faculty of medicine pediatric respirology
Name: MOH SYAROFIL   ANAM
Address:  Bagian/KSM Ilmu Kesehatan Anak FK Undip/RSUP dr. Kariadi Semarang. Jl. dr Sutomo No.16. Gedung C1L2 Japan
Telephone: 081367428988
Email: msanam77@fk.undip.ac.id
Affiliation:  lecturer at diponegoro university faculty of medicine pediatric respirology
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: severe tuberculosis form, include extrapulmonary TB, MDR TB
severe malnutrition
severe chronic disease
acute infectious disease on enrollement or admission
HIV positif


Age minimum: 2years-old
Age maximum: 14years-old
Gender: Male and Female
Health Condition(s) or Problem(s) studied
clinical trial on supplementary drug for tuberculosis in children
Intervention(s)
channa striata extract for 2 month
subject 2-5 years dose 2x250 mg
subject 6-14 years dose 2x500 mg
placebo with same form and eticket, with capsul or syrup glukosa base
Primary Outcome(s)
outcome of tuberculosis in children after 2 month suplementation of channa striata
Secondary Outcome(s)
improvement of albumin level
improvement of leptin level
improvement of cytokine level (TNF-a, IFN-gamma, IGF-beta)
improvement of body mass index
Secondary ID(s)
Source(s) of Monetary Support
faculty of medicine diponegoro university
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date: 21/08/2019
Contact:
komisietik@gmail.com
Komisi Etik Penelitian Kesehatan FK Undip
02476928010 (p.7820)
komisietik@gmail.com
Results
Results available:
Date Posted:
Date Completed: 01/04/2021
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history